Research

Ochsner Health System

The Ochsner Cancer Institute, at Ochsner Health System, is the largest system in the Gulf South region to truly provide multidisciplinary care for cancer patients.  In 2011, over 2400 patients were diagnosed and treated at the Ochsner Cancer Institute.  At Ochsner, our patients benefit from a multidisciplinary collaborative approach to cancer care by a highly skilled team of physicians, oncology nurses, social workers, researchers, and other health care professionals.  These professionals work together to determine each individual patient’s course.  Our patients are prospectively presented in one of nine specific multidisciplinary tumor conferences and treatments are developed using nationally approved guidelines.  At Ochsner, patients benefit from a number of advanced cancer treatment options including minimally invasive robotic surgery, stereotactic radiosurgery, and bone marrow transplant.

To find an Ochsner doctor, click here.

The cancer program at the Ochsner Cancer Institute is fully accredited by the American College of Surgeons Commission on Cancer.  Moreover the Lieselotte Tansey Breast Center at Ochsner is fully accredited by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons.  Ochsner remains the first and only breast center recognized by NAPBC in the Gulf South region.  In 2012, the Ochsner Cancer Institute was recognized by U.S. News and World Report as a “High Performing” Department.

During the past few years, the Ochsner Cancer Institute has made a number of key expansions to the program including the initiation of our Cancer Survivorship Clinic which addresses the specific patient needs related to their cancer and the long term consequences of their treatment.  Through our continued expansion, our physicians remain readily accessible to our partners in the community and our patients thrive on our commitment, compassion and caring.

Clinical Trials and Research

Patients also have the opportunity to participate in clinical research trials from multiple collaborative groups through the Ochsner Community Clinical Oncology Program (CCOP).   Ochsner has been actively involved in cancer research since its inception and is currently the largest clinical research program in Oncology in the New Orleans region. The program currently provides access to our trials at our Jefferson Highway, Baton Rouge, Covington and Baptist sites with plans to expand into our other locations in the future.  By having numerous locations involved in research, Ochsner provides access to clinical trials for patients living in southern Louisiana and parts of Mississippi, with plans underway to geographically increase access.

For a listing of current clinical trials at Ochsner, click here.

The Ochsner CCOP has been continuously funded by the National Cancer Institute (NCI) since 1983 and remains the core of the program. The CCOP provides a direct link to the NCI and participation in clinical trials for the following  research bases: the Eastern Cooperative Oncology Group (ECOG); the National Surgical Adjuvant Breast and Bowel Project (NSABP); the Radiation therapy Oncology Group (RTOG); the North Central Cancer Treatment Group(NCCTG); and the Children’s Oncology Group (COG). This year our program was able to reestablish membership with COG to provide critical access to trials for our pediatric patients.

Evaluation of new treatments and technologies also occurs in collaboration with industry and other national research consortia providing access to cutting edge treatments that are being investigated. The Ochsner Cancer Institute facilitates active involvement of the physicians most responsible for treating cancer patients across the multidisciplinary programs by providing them with important access to research infrastructure.

To learn more about the latest from the Ochsner Cancer Institute, view our Annual Report.